List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 152 studies with search of: "Tetanus"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Tetanus Immunization in Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective Levels
Condition: Tetanus
Interventions: Drug: Tetanus Immune Globulin (Human);   Biological: Diphtheria-Tetanus Toxoids Adsorbed
2 Completed Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td
Conditions: Diphtheria;   Tetanus
Interventions: Biological: TENIVAC™;   Biological: DECAVAC®
3 Completed Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Polio
Intervention: Drug: Boostrix polio
4 Enrolling by invitation An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster
Conditions: Tetanus;   Diphtheria;   Pertussis
Interventions: Biological: Td5ap;   Biological: Td1aP
5 Recruiting Database Surveillance Safety Study of PENTACEL® Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Haemophilus Influenzae
Interventions: Biological: DTaP-IPV/Hib;   Biological: Other DTap Vaccines
6 Completed REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-Old Children
Conditions: Diphtheria;   Tetanus;   Poliomyelitis
Interventions: Biological: REVAXIS®;   Biological: DT-Polio®
7 Enrolling by invitation Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose
Conditions: Pertussis;   Tetanus;   Diphtheria
Interventions: Biological: Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®);   Biological: Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®)
8 Active, not recruiting Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Influenzae Type B
Interventions: Biological: Shan 5;   Biological: Easy Five
9 Completed Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine
Conditions: Meningitis;   Meningococcemia;   Pertussis;   Tetanus;   Diphtheria
Interventions: Biological: T dap + Meningococcal Polysaccharide Diphtheria Toxoid Conj.;   Biological: Tdap + Meningococcal Polysaccharide Diphtheria Toxoid Conj.;   Biological: Meningococcal Polysaccharide Diphtheria Toxoid Conj. + T dap
10 Completed Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Polio;   Haemophilus Influenzae Type B
Intervention: Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis (DAPTACEL®)
11 Completed Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents
Conditions: Neoplasms, Glandular and Epithelial;   Diphtheria;   Tetanus;   Whooping Cough;   Poliomyelitis
Interventions: Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant (qHPV) Vaccine from Current Manufacturing Facility (CMF);   Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant (qHPV) Vaccine from Future Manufacturing Facility (FMF);   Biological: Comparator: REPEVAX™ (Concomitant);   Biological: Comparator: REPEVAX™ (Non-Concomitant)
12 Completed Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents
Conditions: Neoplasms, Glandular and Epithelial;   Diphtheria;   Tetanus;   Whooping Cough;   Meningitis
Interventions: Biological: Comparator: Quadrivalent HPV vaccine;   Biological: Comparator: Menactra™ (Concomitant);   Biological: Comparator: Adacel™ (Concomitant);   Biological: Comparator: Menactra™ (Non-concomitant);   Biological: Comparator: Adacel™
13 Active, not recruiting Safety of DTaP-IPV-HB-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.
Conditions: Diphtheria;   Tetanus;   Pertussis;   Haemophilus Influenzae Type B;   Hepatitis B
Interventions: Biological: DTaP-IPV-HB-PRP~T;   Biological: Tritanrix-HepB/Hib
14 Completed Post-Marketing Safety Study of GSK Biologicals' Boostrix® Vaccine.
Condition: Prophylaxis Against Diphtheria, Tetanus, and Pertussis
Interventions: Biological: Td (Tetanus diphtheria) vaccine;   Biological: Boostrix®
15 Enrolling by invitation Study of the DTacP-IPV-HepB-PRP-T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Poliomyelitis;   Haemophilus Influenzae Type B
Intervention: Biological: DTaP-IPV-HB-PRP~T vaccine
16 Completed Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Infection;   Meningococcal Infection
Interventions: Biological: Mencevax™ ACW;   Biological: Tritanrix™- HepB;   Biological: Hiberix™
17 Active, not recruiting Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP HB PRP~T Combined Vaccine in Filipino Infants
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Heamophilus Influenza
Interventions: Biological: DTaP HB PRP~T Combined Vaccine;   Biological: DTaP-HB-PRP~T vaccine
18 Active, not recruiting Immunogenicity and Safety of Adacel Polio Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Intervention: Biological: TdcP-IPV vaccine
19 Completed Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants
Conditions: Diphtheria;   Tetanus;   Pertussis;   Haemophilus Influenzae Type B;   Poliomyelitis
Interventions: Biological: DTaP-IPV-HB-PRP~T;   Biological: DTaP-IPV//PRP~T combined vaccine & Recombinant hep B vaccine
20 Active, not recruiting Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Influenzae Type B
Intervention: Biological: Shan5

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services